Artificial intelligence (AI) technology is quickly advancing to improve the speed of diagnosis, predict the success of drug discoveries and provide virtual assistance to patients.1 The benefits of this technology (including convenience, improved patient treatment, cost savings and reduction in human errors) makes AI incredibly desirable to over-stretched and budget-restricted healthcare systems, especially the NHS. Read more
Recently, there have been a number of reports and studies exploring the potential therapeutic applications of currently illicit drugs. Cannabis is breaking down barriers in the treatment of certain types of epilepsy in the UK and a marketing application for an intranasal esketamine spray has been submitted to the EMA for treatment-resistant major depressive disorder.
Currently available antidepressants, such as SSRIs, are used collectively to treat major depressive disorder, anxiety and other mood disorders. They have been shown to lack substantial efficacy in all patient populations and are renowned for having a delayed onset of action (Penn and Tracy, 2012). Working in the area of mental health at CHC, coupled with an interest to find out more, we ventured further into a current avenue of research that looked more and more curious…
Over the past couple of months we have been sharing some insights into our Delivering ChangeTM planning model. In the final blog of this series we delve into our ‘Library of Change’. Read more
In this third blog in our series about Delivering Change we provide a brief overview of what CHC means when we talk about change.
‘Change’ has become a buzzword in our industry but more often than not, this ‘change’ only ever relates to behaviour change – changing the prescribing habits of healthcare professionals or changing people’s engagement in their own health. At CHC, we wanted to take this one step further and be more specific about ‘change’. Read more
We’ve been talking a lot about Delivering ChangeTM as of late, and one of the key components of the Delivering ChangeTM process is to seek external sources of inspiration to help drive unexpected creative approaches in our work. With that in mind, three of the team wandered over to the ExCel London for The New Scientist Live 2018. This year, in particular, we were impressed by the various methods of communication. Read on for some of our highlights:
This Friday 10th November is World Science Day for Peace and Development. On this day, a number of events across the world aim to engage people in scientific discussion through innovative and creative communication. This reminds us of an event CHC recently attended at the ExCel Centre in London, the New Scientist Live.
The CHC offices are full of people who have a real passion for science, so it’s important to us that we maintain our curiosity and stay informed. That’s why the CHC team found themselves faced with a 28ft giant inflatable E.coli as we ventured along to two days of New Scientist Live, taking place at the ExCel London.
The hall was split into four themed zones: Technology, Brain & Body, Cosmos and Earth, with each section hosting a number of exhibits and talks. Some of our highlights included:
The future of healthcare –Ruth McKernan of Innovate UK